QuidelOrtho Corporation (QDEL) vs SiBone (SIBN)
QuidelOrtho Corporation and SiBone are both Medical Devices companies. SiBone is the larger, with a market value of $830.0M against $733.1M — 1.1× the size. SiBone grew revenue faster over the last twelve months: 15.3% against −2.46%. SiBone has the higher net margin (−6.85% vs −39.2%) and the lower return on invested capital (−15.4% vs −11.4%). Across the 18 metrics below, SiBone leads on 13 and QuidelOrtho Corporation on 5.
Valuation
Profitability
| Metric | QDEL | SIBN | Medical Devices median |
|---|---|---|---|
| Gross margin | 44.60% | 79.53% | 56.01% |
| Operating margin | (30.84%) | (8.31%) | (15.03%) |
| Net margin | (39.20%) | (6.85%) | (20.40%) |
| Free cash flow margin | (7.90%) | (2.05%) | (7.24%) |
| Return on equity | (45.91%) | (8.30%) | (15.32%) |
| Return on assets | (17.34%) | (6.10%) | (19.72%) |
| Return on invested capital | (11.35%) | (15.40%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack